Nabiximols: all 61 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Proof of Concept Trial of Cannabis Derivatives in Neuropathic PainRecruitingNCT05351801Phase 2
• Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisTerminatedNCT04984278Phase 3Results posted
• Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisCompletedNCT04657666Phase 3Results posted
• Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple SclerosisTerminatedNCT04203498Phase 3Results posted
• Trial of Cannabis for Essential TremorCompletedNCT03805750Phase 1/2Results posted
• A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis PatientsCompletedNCT01964547Phase 4Results posted
• Fixed or Self-Titrated Dosages of Sativex on Cannabis UsersCompletedNCT01748799Not applicableResults posted
• Sativex and Behavioral-relapse Prevention Strategy in Cannabis DependenceCompletedNCT01747850Phase 2Results posted
• An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple SclerosisCompletedNCT01610713Phase 3Results posted
• An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis PatientsCompletedNCT01610700Phase 3Results posted
• A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple SclerosisCompletedNCT01610687Phase 3Results posted
• A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord InjuryCompletedNCT01606202Phase 3Results posted
• A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury PainCompletedNCT01606189Phase 3Results posted
• A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological OriginCompletedNCT01606176Phase 3Results posted
• A Study of the Long-term Safety of Sativex UseCompletedNCT01606137Phase 3Results posted
• A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple SclerosisCompletedNCT01604265Phase 3Results posted
• A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple SclerosisCompletedNCT01599234Phase 3Results posted
• A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced CancerCompletedNCT01424566Phase 3Results posted
• Sativex® for Relieving Persistent Pain in Patients With Advanced CancerCompletedNCT01361607Phase 3Results posted
• Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related PainCompletedNCT01337089Phase 3Results posted
• Sativex® for Relieving Persistent Pain in Participants With Advanced CancerCompletedNCT01262651Phase 3Results posted
• A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic PainCompletedNCT00713817Phase 3Results posted
• A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.CompletedNCT00713323Phase 3Results posted
• A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.CompletedNCT00711880Phase 3Results posted
• A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.CompletedNCT00711646Phase 3Results posted
• A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With AllodyniaCompletedNCT00710554Phase 3Results posted
• A Study of Sativex® for Pain Relief Due to Diabetic NeuropathyCompletedNCT00710424Phase 3Results posted
• Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple SclerosisCompletedNCT00702468Phase 3Results posted
• A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)CompletedNCT00681538Phase 3Results posted
• A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple SclerosisCompletedNCT00678795Phase 3Results posted
• Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related PainCompletedNCT00675948Phase 3Results posted
• A Study of Sativex® for Pain Relief in Patients With Advanced MalignancyCompletedNCT00674609Phase 3Results posted
• A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.CompletedNCT00530764Phase 2Results posted
• Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MSCompletedNCT00391079Phase 3Results posted
• A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum DisordersWithdrawnNCT05974293Phase 2
• The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and CannabidiolActive, not recruitingNCT05742724Phase 1
• Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)Status unknownNCT05503147Phase 1
• Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the KneeStatus unknownNCT04992962Phase 2
• Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress DisorderWithdrawnNCT04592159Phase 2/3
• The Effect of Cannabis in Pancreatic CancerWithdrawnNCT03245658Phase 2
• The Role of SAtivex® in Robotic-RehabilitationCompletedNCT03186664Not applicable
• CANNAbinoids in the Treatment of TICS (CANNA-TICS)CompletedNCT03087201Phase 3
• A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced CancerWithdrawnNCT02432612Phase 1
• A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.WithdrawnNCT02325024Phase 1
• An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.CompletedNCT02325011Phase 1
• Experimental Medicine in ADHD - CannabinoidsCompletedNCT02249299Not applicable
• A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy SubjectsTerminatedNCT02240160Phase 1
• A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced MucositisTerminatedNCT01975688Phase 1
• A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 YearsCompletedNCT01898520Phase 3
• Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy PatientsCompletedNCT01887301Phase 1
• Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.WithdrawnNCT01868048Phase 3
• A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma PatientsCompletedNCT01812616Phase 1/2
• A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent GlioblastomaCompletedNCT01812603Phase 1/2
• Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron DiseaseCompletedNCT01776970Phase 2/3
• Neurophysiological Study of Sativex in Multiple Sclerosis (MS) SpasticityCompletedNCT01538225Phase 3
• Abuse Potential of SativexCompletedNCT01323569Phase 1
• Study to Assess Food Effect on Sativex BioavailabilityCompletedNCT01322464Phase 1
• Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain ActivationCompletedNCT01037608Phase 1
• Sativex for Treatment of Chemotherapy Induced Neuropathic PainCompletedNCT00872144Phase 3
• Combination of an Investigational Cannabinoid and Methadone for HIV-associated NeuropathyWithdrawnNCT00723918Phase 2
• Use of Cannabinoids in Patients With Multiple SclerosisStatus unknownNCT00202423Phase 2

← Nabiximols overview